Prion infections, blood and transfusions

Nature Clinical Practice Neurology

Volumn 2, Issue 6, 2006, Pages 321-329

  Aguzzi, Adriano ^a,c   Glatzel, Markus ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Blood; Creutzfeldt Jakob disease; Dementia; Infection; Prions

Indexed keywords

TISSUE EXTRACT;

BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CENTRAL NERVOUS SYSTEM DISEASE; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST; DISEASE MARKER; DISEASE TRANSMISSION; HUMAN; IATROGENIC DISEASE; INFECTION RISK; LYMPHOID ORGAN; NEUROSURGERY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK MANAGEMENT; RODENT; SCRAPIE; SHEEP; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; HUMANS; PRION DISEASES;

EID: 33744511127     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0214     Document Type: Review

References (50)

1. Silveira JR et al. (2005) The most infectious prion protein particles. Nature 437: 257-261
2. Aguzzi A and Miele G (2004) Recent advances in prion biology. Curr Opin Neurol 17: 337-342
3. Brandner S et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339-343
4. Mead S et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300: 640-643
5. Creutzfeldt HG (1920) Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z ges Neurol Psychiatr 57: 1-19
6. Aguzzi A and Polymenidou M (2004) Mammalian prion biology: One century of evolving concepts. Cell 116: 313-327
7. Jakob A (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde. (Spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Z ges Neurol Psychiatr 64: 147-228
8. Glatzel M et al. (2005) Human prion diseases: Molecular and clinical aspects. Arch Neurol 62: 545-652
9. Ghani AC et al. (2002) The transmission dynamics of BSE and vCJD. CR Biol 325: 37-47
10. Hill AF et al. (1997) The same prion strain causes vCJD and BSE. Nature 389: 448-450
11. Bruce ME et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389: 498-501
12. Aguzzi A and Weissmann C (1996) Spongiform encephalopathies: A suspicious signature. Nature 383: 666-667
13. Aguzzi A (1996) Between cows and monkeys. Nature 381: 734
14. Andrews NJ et al. (2003) Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 361: 751-752
15. The National Creutzfeldt-Jakob Disease Surveillance Unit [http://www.cjd.ed.ac.uk]
16. Frigg R et al. (1999) Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J Virol 73: 9584-9588
17. Hilton DA et al. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203: 733-739
18. Peden AH et al. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527-529
19. Collins S et al. (1999) Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case-control study. Lancet 353: 693-697
20. Brown P et al. (1994) Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513-529
21. Glatzel M et al. (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349: 1812-1820
22. Ricketts MN et al. (1997) Is Creutzfeldt-Jakob disease transmitted in blood? Emerg Infect Dis 3: 155-163
23. Bruce ME et al. (2001) Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358:208-209
24. Hill AF et al. (1997) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349: 99
25. Llewelyn CA et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 41 7-421
26. Health Protection Agency press statement: New case of variant CJD associated with blood transfusion [http://www.hpa.org.uk/hpa/news/articles/press_releases/2006/ 060209_cjd.htm]
27. Weissmann C and Aguzzi A (1997) Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease. Curr Opin Neurobiol 7: 695-700
28. Casalone C et al. (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: Molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 101: 3065-3070
29. Heikenwalder M et al. (2005) Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307: 1107-1110
30. Wells GA et al. (2005) Pathogenesis of experimental bovine spongiform encephalopathy: Preclinical infectivity in tonsil and observations on the distribution of lingual tonsil in slaughtered cattle. Vet Rec 156: 401-407
31. Buschmann A and Groschup MH (2005) Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis 192: 934-942
32. Ryder S et al. (2004) Demonstration of lateral transmission of scrapie between sheep kept under natural conditions using lymphoid tissue biopsy. Res Vet Sci 76: 211-217
33. Seeger H et al. (2005) Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310: 324-326
34. Houston F et al. (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356: 999-1000
35. Hunter N et al. (2002) Transmission of prion diseases by blood transfusion. J Gen Virol 83: 2897-2905
36. Brown P et al. (1998) The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38: 810-816
37. Holada K et al. (2002) Scrapie infectivity in hamster blood is not associated with platelets. J Virol 76: 4649-4650
38. Gregori L et al. (2004) Partitioning of TSE infectivity during ethanol fractionation of human plasma. Biologicals 32: 1-10
39. DebBurman SK et al. (1997). Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 94: 13938-13943
40. Fischer MB et al. (2000) Binding of disease-associated prion protein to plasminogen. Nature 408: 479-483
41. Sc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4: 805-814
42. Bolton DC et al. (1991) Molecular location of a species-specific epitope on the hamster scrapie agent protein. J Virol 65: 3667-3675
43. Sc)-specific epitope defined by a monoclonal antibody. Nature 390: 74-77
44. Saborio GP et al. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813
45. Castilla J et al. (2005) Detection of phons in blood. Nat Med 11: 982-985
46. Miele G et al. (2001) A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat Med 7: 361-364
47. Maury C (2001) Is EDRF a specific marker for TSEs? Nat Med 7: 641-642
48. Wilson K and Ricketts MN (2004) Transfusion transmission of vCJD: A crisis avoided? Lancet 364: 477-479
49. Sowemimo-Coker S et al. (2005) Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter. Transfusion 45: 1839-1844
50. Sc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 3: E14